Herrera-García JC, Sánchez-Pérez R, Arroyo-Cabrera C, Nuche-Salazar P

Language: Spanish
References: 28
Page: 30-35
PDF size: 342.26 Kb.

ABSTRACT

The hemoptysis is a complication commonly reported in patients diagnosed with cystic fibrosis and affects approximately 9% of the population. It may be in limited quantity to massive events that threaten the patient’s life. Its pathogenesis is complex, but the most commonly accepted cause is persistent airway inflammation associated with neovascularization with damage to the vasculature of the bronchial arteries. The case of a 22 year old with confirmed diagnosis of cystic fibrosis in whom control of hemoptysis was achieved through embolization of bronchial arteries and placement PLUG IV Occluder device percutaneously successfully described.

REFERENCES

1. Flume PA. Pulmonary complications of cystic fibrosis. Respir Care 2009; 54(5): 618-27.

2. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest 2005; 128: 729-38.

3. Consenso de fibrosis quística. Arch Argent Pediatr 1999; 97: 188-224.

4. Prados C, Máiz L, Antelo C, Baranda F, Blázquez J, Borro JM, et al. Cystic fibrosis: consensus on the treatment of pneumothorax and massive hemoptysis and on the indications for lung transplantation. Arch Bronconeumol 2000; 36(7): 411-6.

5. Charan NB, Baile EM, Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997; 10: 1173-80.

6. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001; 164: S39-S45.

7. Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38: 572-8.

8. Parker CM, Nolan R, Lougheed MD. Catamenial hemoptysis and pneumothoracesin a patient with cystic fibrosis. Can Respir J 2007; 14: 295-7.

9. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001; 164: S39-S45.

10. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young childrenwith cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100.

11. Barben JU, Ditchfield M, Carlin JB, Robertson CF, Robinson PJ, Olinsky A. Major haemoptysis in children with cystic fibrosis: a 20- year retrospective study. J Cyst Fibr 2003; 2: 105-11.

12. Popper J. The use of premarin IV in hemoptysis. Dis Chest 1960; 37: 659-60.

13. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993; 15: 187-98.

14. Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee. Am J Respir Crit Care Med 2010; 182: 298-306.

15. Coss-Bu JA, Sachdeva RC, Bricker JT, Harrison GM, Jefferson LS. Hemoptysis: a 10-year retrospective study. Pediatrics 1997; 100: E7.

16. Sidhu M, Wieseler K, Burdick TR, Shaw DW. Bronchial artery embolization for hemoptysis. Semin Intervent Radiol 2008; 25: 310-8.

17. Barben J, Robertson D, Olinsky A, Ditchfield M. Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis. Radiology 2002; 224: 124-30.

18. Antonelli M, Midulla F, Tancredi G, Salvatori FM, Bonci E, Cimino G, Flaishman I. Bronchial artery embolization for the management of non massive hemoptysis in cystic fibrosis. Chest 2002; 121: 796-801.

19. Colson DJ, Mortelliti AJ. Management of pediatric hemoptysis: Review and a case of isolated unilateral pulmonary artery agenesis. Int J Pediatr Otorhinolaryngol 2005; 69: 1161-7.

20. Rolla M, D’Andrilli A, Rendina EA, Diso D, Venuta F. Cystic fibrosis and the thoracic surgeon. Eur J Cardiothorac Surg 2011; 39: 716-25.

21. Weiping Wang, Hongcui Li, Matthew D. Tam, Dayong Zhou, David X. Wang, James Spain. The Amplatzer Vascular Plug: A Review of the Device and its Clinical Applications. Cardiovasc Intervent Radiol 2012; 35(4): 725-40. Órgano de Difusión de la Sociedad de Médicos Revista de Investigación

22. Graff GR. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. Respiration 2001; 68: 91-4.

23. Flume PA, et al. Massive hemoptysis in cystic fibrosis. Chest 2005; 128: 729-38.

24. Sopko DR, Smith TP. Bronchial artery embolization for hemoptysis. Seminars in Interventional Radiology 2011; 28(1): 48-62

25. Angle JF, Siddiqi NH, Wallace MJ, Kundu S, Stokes L, Wojak JC, Cardella JF. Quality Improvement Guidelines for Percutaneous Transcatheter Embolization: Society of Interventional Radiology Standards of Practice Committee. JVIR 2010; 21(10): 1479-86.

26. Hurt K, Simmonds NJ. Cystic Fibrosis: Management of Haemoptysis. Paediatr Respir Rev 2012; 13: 200-5.

27. Flume PA, MogayzelJr PJ, Robinson KA, et al. Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax. Am J RespirCrit Care Med 2010; 182: 298-306.

28. Ryan G, Jahnke N, Remmington T. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Cochrane Database of Systematic Reviews 2012; 12: CD008319.